Esther Méndez Arias: Why a Lower First Dose of 4F-PCC Works Better After Cardiac Surgery
Esther Méndez Arias, President of the Transfusion Committe at Bellvitge University Hospital, Coordinator of the Working Group on Digital Transformation and Innovation, Spanish Society of Anaesthesiology at SEDAR, shared Journal Cardiothoracic Vascular Anesthesia‘s post on LinkedIn:
“At our centre, we usually administer 10–15 IU/kg of four-factor prothrombin complex concentrate for bleeding after cardiac surgery, once residual heparin, hypofibrinogenaemia and platelet abnormalities have been corrected.
We then reassess both bleeding and ROTEM findings, and administer a second dose only if microvascular bleeding and coagulopathy consistent with coagulation factor deficiency persist.
For this reason, the median dose of 3,000 IU —approximately 36 IU/kg— used in the retrospective study by Vander Zwaag et al. seems excessive to us as an initial strategy.
We favour a stepwise approach: a low initial dose, early reassessment and redosing only when necessary, without attempting to normalise an isolated EXTEM-CT value.
This is in line with the European consensus by Erdoes et al., developed within the EACTA, which suggests considering an initial dose of 12.5 IU/kg in patients at high thromboembolic risk, such as those undergoing cardiac surgery.”
Journal Cardiothoracic Vascular Anesthesia shared a post on LinkedIn about recent article by Daniel Bolliger et al, published in JCVA, adding:
“How To Dose Prothrombin Complex Concentrates in Bleeding Patients After Cardiac Surgery
How should we dose prothrombin complex concentrate in bleeding cardiac surgery patients?
This editorial argues that ROTEM clotting time poorly reflects thrombin generation, cautioning against high doses and purely viscoelastic-guided dosing.”
Title: How To Dose Prothrombin Complex Concentrates in Bleeding Patients After Cardiac Surgery
Authors: Daniel Bollige, Eckhard Mauermann, Kenichi A. Tanaka
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 29, 2026, 17:41Seema Dawood: Difference Between CBC Smear Staining and Cell Counts Staining
-
Jul 29, 2026, 16:30Mostafa Faisal: Impact of DNMT3A and TET2 Mutations on Clotting and Bleeding in PV and ET
-
Jul 29, 2026, 16:01Gerardo Moscatelli: The Spike Protein Cascade – From Endothelial Binding to Vascular Collapse
-
Jul 29, 2026, 15:42Julie Cardoso: FDA Clears the First AI-Guided Ultrasound Software for Suspected DVT
-
Jul 29, 2026, 15:26Ahmad Alkhammash: Completing an Advanced Fellowship in Adult Thrombosis Medicine
-
Jul 29, 2026, 15:13Yara Mahmoud: The Molecular Basis in Hematology
-
Jul 29, 2026, 15:11Louisa Jorm: A New Era of Dynamic Cardiovascular Risk Assessment
-
Jul 29, 2026, 15:04Filippo Consonni: Treatment Strategies for Hematologic Immune Dysregulation in Inborn Errors of Immunity
-
Jul 29, 2026, 14:53Samer Alsaid: Warfarin Outcomes Reassessed Through COMBINE AF